{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:31:07Z","timestamp":1793845867123,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute, National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health and Human Services"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ophtha.2020.06.038","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:35:56Z","timestamp":1593218156000},"page":"100-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT"],"prefix":"10.1016","volume":"128","author":[{"given":"Tiarnan D.L.","family":"Keenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci E.","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8145-9619","authenticated-orcid":false,"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Elman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Havilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4496-8462","authenticated-orcid":false,"given":"Gidi","family":"Benyamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2020.06.038_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/eye.2015.288","article-title":"Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013","volume":"30","author":"Quartilho","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2020.06.038_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2020.06.038_bib3","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","article-title":"Age-Related Macular Degeneration Preferred Practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Group","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2020.06.038_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/IAE.0000000000000483","article-title":"Identification of fluid on optical coherence tomography by treating ophthalmologists versus a reading center in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"35","author":"Toth","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2020.06.038_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/eye.2016.227","article-title":"A\u00a0view of the current and future role of optical coherence tomography in the management of age-related macular degeneration","volume":"31","author":"Schmidt-Erfurth","year":"2017","journal-title":"Eye (Lond)"},{"issue":"Suppl 1","key":"10.1016\/j.ophtha.2020.06.038_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41433-018-0300-3","article-title":"Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service","volume":"33","author":"Gale","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2020.06.038_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ophtha.2012.06.040","article-title":"Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"119","author":"DeCroos","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib9","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ophtha.2020.06.038_bib10","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","article-title":"Prevalence of age-related macular degeneration in Europe: the past and the future","volume":"124","author":"Colijn","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ophtha.2011.12.016","article-title":"HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration","volume":"119","author":"Singer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.oret.2019.06.001","article-title":"Visual acuity outcomes after anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Age-Related Eye Disease Study 2 Report Number 19","volume":"4","author":"Keenan","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2020.06.038_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.7.4.8","article-title":"Safety and feasibility of a novel sparse optical coherence tomography device for patient-delivered retina home monitoring","volume":"7","author":"Maloca","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ophtha.2020.06.038_bib14","doi-asserted-by":"crossref","first-page":"OCT1","DOI":"10.1167\/iovs.16-19963","article-title":"The development, commercialization, and impact of optical coherence tomography","volume":"57","author":"Fujimoto","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2020.06.038_bib16","unstructured":"Zeiss. Zeiss Cirrus 6000. 2019. Available at: https:\/\/www.zeiss.com\/meditec\/us\/products\/ophthalmology-optometry\/retina\/diagnostics\/optical-coherence-tomography\/oct-optical-coherence-tomography\/cirrus-6000-performance-oct.html. Accessed 11\/27\/2019."},{"key":"10.1016\/j.ophtha.2020.06.038_bib17","unstructured":"Heidelberg Engineering. Spectralis. Multimodal imaging platform optimized for the posterior segment.\u00a02019. Available at: https:\/\/business-lounge.heidelbergengineering.com\/us\/en\/products\/spectralis\/. Accessed 11\/27\/2019."},{"key":"10.1016\/j.ophtha.2020.06.038_bib18","unstructured":"Heidelberg Engineering. Heidelberg Eye Explorer. Next-generation platform for Heidelberg engineering device management and integration.\u00a02019. Available at: https:\/\/business-lounge.heidelbergengineering.com\/us\/en\/products\/heyex\/. Accessed 11\/27\/2019."},{"key":"10.1016\/j.ophtha.2020.06.038_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","article-title":"A\u00a0paradigm shift in imaging biomarkers in neovascular age-related macular degeneration","volume":"50","author":"Schmidt-Erfurth","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2020.06.038_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.oret.2017.03.015","article-title":"Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration","volume":"2","author":"Schmidt-Erfurth","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2020.06.038_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ophtha.2016.03.037","article-title":"Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW Trials","volume":"123","author":"Waldstein","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ophtha.2016.04.005","article-title":"Automated identification of lesion activity in neovascular age-related macular degeneration","volume":"123","author":"Chakravarthy","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib23","series-title":"A\u00a0novel AI-based algorithm for quantifying volumes of retinal pathologies in OCT scans","author":"Goldstein","year":"2019"},{"key":"10.1016\/j.ophtha.2020.06.038_bib24","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib25","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2020.06.038_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Comparison of Age-related Macular Degeneration Treatments Trials Research Group","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","article-title":"The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity","volume":"121","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ophtha.2020.06.038_bib30","doi-asserted-by":"crossref","first-page":"m689","DOI":"10.1136\/bmj.m689","article-title":"Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies","volume":"368","author":"Nagendran","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2020.06.038_bib31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gutjnl-2018-317500","article-title":"Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ophtha.2020.06.038_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12886-016-0207-3","article-title":"The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study","volume":"16","author":"Arnold","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2020.06.038_bib34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2015.12.002","article-title":"Macular morphology and visual acuity in the second year of the comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","article-title":"Fully automated detection and quantification of macular fluid in OCT using deep learning","volume":"125","author":"Schlegl","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.038_bib36","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2020.06.038_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2018.04.007","article-title":"Automated segmentation of lesions including subretinal hyperreflective material in neovascular age-related macular degeneration","volume":"191","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2020.06.038_bib38","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1364\/BOE.8.003440","article-title":"Deep-learning based, automated segmentation of macular edema in optical coherence tomography","volume":"8","author":"Lee","year":"2017","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ophtha.2020.06.038_bib39","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1364\/BOE.7.001577","article-title":"Automated volumetric segmentation of retinal fluid on optical coherence tomography","volume":"7","author":"Wang","year":"2016","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ophtha.2020.06.038_bib40","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1109\/TMI.2015.2408632","article-title":"Stratified sampling voxel classification for segmentation of intraretinal and subretinal fluid in longitudinal clinical OCT data","volume":"34","author":"Xiayu","year":"2015","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.ophtha.2020.06.038_bib41","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1364\/BOE.6.001172","article-title":"Kernel regression based segmentation of optical coherence tomography images with diabetic macular edema","volume":"6","author":"Chiu","year":"2015","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ophtha.2020.06.038_bib42","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1167\/iovs.12-10083","article-title":"Quantification of external limiting membrane disruption caused by diabetic macular edema from SD-OCT","volume":"53","author":"Chen","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2020.06.038_bib43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1109\/TBME.2012.2184759","article-title":"Automated segmentation of intraretinal cystoid fluid in optical coherence tomography","volume":"59","author":"Wilkins","year":"2012","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.ophtha.2020.06.038_bib44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1109\/TMI.2005.848655","article-title":"Delineating fluid-filled region boundaries in optical coherence tomography images of the retina","volume":"24","author":"Fernandez","year":"2005","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.ophtha.2020.06.038_bib45","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1364\/BOE.9.001545","article-title":"Deep\u00a0learning approach for the detection and quantification of intraretinal cystoid fluid in multivendor optical coherence tomography","volume":"9","author":"Venhuizen","year":"2018","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ophtha.2020.06.038_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40123-019-00207-y","article-title":"Optical coherence tomography-based deep-learning models for classifying normal and age-related macular degeneration and exudative and non-exudative age-related macular degeneration changes","volume":"8","author":"Motozawa","year":"2019","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:10:34Z","timestamp":1758982234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642020305807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0161642020305807"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.038","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}